Study / S68QGTYNT2023-01-11

Genomic characterization and therapeutic utilization of IL-13-responsive sequences in asthma

Kyung Duk Koh, Luke R Bonser, Walter L Eckalbar, Ofer Yizhar-Barnea, Jiangshan Shen et al.

About this study

Epithelial responses to the cytokine interleukin-13 (IL-13) cause airway obstruction in asthma. Here we utilized multiple genomic techniques to identify IL-13-responsive regulatory elements in bronchial epithelial cells and used these data to develop a CRISPR interference (CRISPRi)-based therapeutic approach to downregulate airway obstruction-inducing genes in a cell type- and IL-13-specific manner. Using single-cell RNA sequencing (scRNA-seq) and acetylated lysine 27 on histone 3 (H3K27ac) chromatin immunoprecipitation sequencing (ChIP-seq) in primary human bronchial epithelial cells, we identified IL-13-responsive genes and regulatory elements. These sequences were functionally validated and optimized via massively parallel reporter assays (MPRAs) for IL-13-inducible activity. The top secretory cell-selective sequence from the MPRA, a novel, distal enhancer of the sterile alpha motif pointed domain containing E-26 transformation-specific transcription factor (SPDEF) gene, was utilized to drive CRISPRi and knock down SPDEF or mucin 5AC (MUC5AC), both involved in pathologic mucus production in asthma. Our work provides a catalog of cell type-specific genes and regulatory elements involved in IL-13 bronchial epithelial response and showcases their use for therapeutic purposes.

Full author list & citation

Kyung Duk Koh, Luke R Bonser, Walter L Eckalbar, Ofer Yizhar-Barnea, Jiangshan Shen, Xiaoning Zeng, Kirsten L Hargett, Dingyuan I Sun, Lorna T Zlock, Walter E Finkbeiner, Nadav Ahituv, David J Erle. Genomic characterization and therapeutic utilization of IL-13-responsive sequences in asthma. 2023-01-11. https://doi.org/10.1016/j.xgen.2022.100229

Experiments 2

E33T2U5P0

SPDEFe(1-200) saturation mutagenesis lentiMPRA

A lentiviral MPRA tested all 600 possible single-nucleotide substitutions across bases 1-200 of the 589-bp SPDEFe enhancer in primary human bronchial epithelial cells from two donors. Cells were cultured at an air-liquid interface with or without IL-13, and the table reports pooled variant effects relative to the wild-type sequence.

Integrated lentiMPRAHumanGRCh38
Explore data
E3GRTQLJK

H3K27ac-guided cis-regulatory-sequence lentiMPRA

A lentiviral MPRA tested 1,904 candidate cis-regulatory sequences selected from IL-13-responsive H3K27ac peaks in primary human bronchial epithelial cells from two donors. Cells were cultured at an air-liquid interface with or without IL-13, and the table reports pooled and donor-level RNA/DNA activity measurements and the authors' IL-13 response calls.

Integrated lentiMPRAHumanGRCh38
Explore data

Raw source data 8 files

Original supplemental and deposited inputs retained for this study. Download files individually or together as a ZIP; nested folders are preserved. Source reuse terms apply, and sequencing reads may be omitted.

Download all 8 files (ZIP)article_fulltext.xmlDocument_S2_article_plus_supplement.pdfSHA256SUMS.txtsource_notes.txtTable_S10_SPDEFe_saturation_mutagenesis_MPRA.xlsxTable_S10_SPDEFe_saturation_mutagenesis_MPRA_source.csvTable_S11_H3K27ac_CRS_MPRA.xlsxTable_S11_H3K27ac_CRS_MPRA_source.csv

Cite OpenMPRA

Cite the OpenMPRA database. Include your access date because the collection changes over time.

Please also cite the source studies when using their data.